Works matching AU Kobe, Carsten

Results: 81
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Intraindividual comparison of <sup>18</sup>F‐PSMA‐1007 with renally excreted PSMA ligands for PSMA‐PET imaging in patients with relapsed prostate cancer.

    Published in:
    Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.234898
    By:
    • Dietlein, Felix;
    • Kobe, Carsten;
    • Hohberg, Melanie;
    • Zlatopolskiy, Boris D.;
    • Krapf, Philipp;
    • Endepols, Heike;
    • Täger, Philipp;
    • Hammes, Jochen;
    • Heidenreich, Axel;
    • Persigehl, Thorsten;
    • Neumaier, Bernd;
    • Drzezga, Alexander;
    • Dietlein, Markus
    Publication type:
    Article
    14

    A novel <sup>18</sup>F‐labeled PSMA ligand for PET/CT imaging of prostate cancer patients: First ‐in‐man observational study and clinical experience with <sup>18</sup>F‐JK‐PSMA‐7 during the first year of application.

    Published in:
    Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.229542
    By:
    • Dietlein, Felix;
    • Hohberg, Melanie;
    • Kobe, Carsten;
    • Zlatopolskiy, Boris D.;
    • Krapf, Philipp;
    • Endepols, Heike;
    • Täger, Philipp;
    • Hammes, Jochen;
    • Heidenreich, Axel;
    • Neumaier, Bernd;
    • Drzezga, Alexander;
    • Dietlein, Markus
    Publication type:
    Article
    15
    16
    17
    18
    19
    20

    Quantitative Analysis of Response to Treatment with Erlotinib in Advanced Non--Small Cell Lung Cancer Using <sup>18</sup>F-FDG and 3'-Deoxy-3'-<sup>18</sup>F-Fluorothymidine PET.

    Published in:
    Journal of Nuclear Medicine, 2011, v. 52, n. 12, p. 1871, doi. 10.2967/jnumed.111.094458
    By:
    • Kahraman, Deniz;
    • Scheffler, Matthias;
    • Zander, Thomas;
    • Nogova, Lucia;
    • Lammertsma, Adriaan A.;
    • Boellaard, Ronald;
    • Neumaier, Bernd;
    • Ullrich, Roland T.;
    • Holstein, Arne;
    • Dietlein, Markus;
    • Wolf, Jürgen;
    • Kobe, Carsten
    Publication type:
    Article
    21

    Downregulation of <sup>18</sup>F-FDG Uptake in PET as an Early Pharmacodynamic Effect in Treatment of Non-Small Cell Lung Cancer with the mTOR Inhibitor Everolimus.

    Published in:
    Journal of Nuclear Medicine, 2009, v. 50, n. 11, p. 1815, doi. 10.2967/jnumed.109.065367
    By:
    • Nogová, Lucia;
    • Boellaard, Ronald;
    • Kobe, Carsten;
    • Hoetjes, Nikie;
    • Zander, Thomas;
    • Gross, Stefan Hubert;
    • Dimitrijevic, Sasa;
    • Pellas, Theodore;
    • Eschner, Wolfgang;
    • Schmidt, Katja;
    • Bangard, Christopher;
    • Hayes, Wendy;
    • Thomas, Roman K.;
    • Dietlein, Markus;
    • Giaccone, Giuseppe;
    • Hoekstra, Otto S.;
    • Lammertsma, Adriaan A.;
    • Wolf, Jürgen
    Publication type:
    Article
    22
    23

    Dosimetry-based treatment planning for molecular radiotherapy: a summary of the 2017 report from the Internal Dosimetry Task Force.

    Published in:
    EJNMMI Physics, 2017, v. 4, n. 1, p. 1, doi. 10.1186/s40658-017-0194-3
    By:
    • Stokke, Caroline;
    • Gabiña, Pablo;
    • Solný, Pavel;
    • Cicone, Francesco;
    • Sandström, Mattias;
    • Gleisner, Katarina;
    • Chiesa, Carlo;
    • Spezi, Emiliano;
    • Paphiti, Maria;
    • Konijnenberg, Mark;
    • Aldridge, Matt;
    • Tipping, Jill;
    • Wissmeyer, Michael;
    • Brans, Boudewijn;
    • Bacher, Klaus;
    • Kobe, Carsten;
    • Flux, Glenn
    Publication type:
    Article
    24

    Sorafenib and everolimus in patients with advanced solid tumors and KRAS‐mutated NSCLC: A phase I trial with early pharmacodynamic FDG‐PET assessment.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 14, p. 4991, doi. 10.1002/cam4.3131
    By:
    • Nogova, Lucia;
    • Mattonet, Christian;
    • Scheffler, Matthias;
    • Taubert, Max;
    • Gardizi, Masyar;
    • Sos, Martin L.;
    • Michels, Sebastian;
    • Fischer, Rieke N.;
    • Limburg, Meike;
    • Abdulla, Diana S.Y.;
    • Persigehl, Thorsten;
    • Kobe, Carsten;
    • Merkelbach‐Bruse, Sabine;
    • Franklin, Jeremy;
    • Backes, Heiko;
    • Schnell, Roland;
    • Behringer, Dirk;
    • Kaminsky, Britta;
    • Eichstaedt, Martina;
    • Stelzer, Christoph
    Publication type:
    Article
    25

    Role of [18F]-fluoro-2-deoxy- d-glucose positron emission tomography in early and late therapy assessment of patients with advanced Hodgkin lymphoma treated with bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine and prednisone.

    Published in:
    Leukemia & Lymphoma, 2012, v. 53, n. 1, p. 64, doi. 10.3109/10428194.2011.603444
    By:
    • Markova, Jana;
    • Kahraman, Deniz;
    • Kobe, Carsten;
    • Skopalova, Magdalena;
    • Mocikova, Heidi;
    • Klaskova, Katerina;
    • Dedeckova, Katerina;
    • Eich, Hans-Theodor;
    • Böll, Boris;
    • Dietlein, Markus;
    • Kozak, Tomas
    Publication type:
    Article
    26
    27

    S218: CORRELATION BETWEEN PROGRESSION‐FREE AND OVERALL SURVIVAL IN PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA: A COMPREHENSIVE ANALYSIS OF INDIVIDUAL PATIENT DATA FROM RANDOMIZED GHSG TRIALS.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000967784.58441.b3
    By:
    • Bröckelmann, Paul;
    • Müller, Horst;
    • Gillessen, Sarah;
    • Jacob, Anne Sophie;
    • Momotow, Jesko;
    • Damaschin, Carla;
    • Ferdinandus, Justin;
    • Yang, Xiaoqin;
    • Fuchs, Michael;
    • Kobe, Carsten;
    • Eich, Hans T.;
    • Engert, Andreas;
    • Borchmann, Peter;
    • Von Tresckow, Bastian
    Publication type:
    Article
    28

    Outcome Prediction in Patients With Large B‐cell Lymphoma Undergoing Chimeric Antigen Receptor T‐cell Therapy.

    Published in:
    HemaSphere, 2023, v. 7, n. 1, p. e817, doi. 10.1097/HS9.0000000000000817
    By:
    • Voltin, Conrad‐Amadeus;
    • Gödel, Philipp;
    • Beckmann, Laura;
    • Heger, Jan‐Michel;
    • Kobe, Carsten;
    • Kutsch, Nadine;
    • Borchmann, Peter;
    • Dietlein, Markus;
    • Herrmann, Ken;
    • Stelljes, Matthias;
    • Rahbar, Kambiz;
    • Lenz, Georg;
    • Reinhardt, H. Christian;
    • Teichert, Marcel;
    • Noppeney, Richard;
    • Albring, Jörn C.;
    • Seifert, Robert;
    • von Tresckow, Bastian;
    • Flossdorf, Sarah;
    • Hanoun, Christine
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35

    AFM13 in patients with relapsed or refractory classical Hodgkin lymphoma: final results of an open-label, randomized, multicenter phase II trial.

    Published in:
    Leukemia & Lymphoma, 2022, v. 63, n. 8, p. 1871, doi. 10.1080/10428194.2022.2095623
    By:
    • Sasse, Stephanie;
    • Bröckelmann, Paul Jan;
    • Momotow, Jesko;
    • Plütschow, Annette;
    • Hüttmann, Andreas;
    • Basara, Nadezda;
    • Koenecke, Christian;
    • Martin, Sonja;
    • Bentz, Martin;
    • Grosse-Thie, Christina;
    • Thorspecken, Sven;
    • de Wit, Maike;
    • Kobe, Carsten;
    • Dietlein, Markus;
    • Tresckow, Bastian von;
    • Fuchs, Michael;
    • Borchmann, Peter;
    • Engert, Andreas
    Publication type:
    Article
    36
    37

    Volumetric assessment of mediastinal lymphoma masses in Hodgkin lymphoma.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 13, p. 3244, doi. 10.1080/10428194.2019.1623888
    By:
    • Baues, Christian;
    • Görgen, Helen;
    • Semrau, Robert;
    • Nast-Kolb, Beatrix;
    • Assenmacher, Katja;
    • Celik, Eren;
    • Morgenthaler, Janis;
    • Rosenbrock, Johannes;
    • Trommer, Maike;
    • Houbois, Christian;
    • Kobe, Carsten;
    • Kriz, Jan;
    • Engert, Andreas;
    • Marnitz, Simone
    Publication type:
    Article
    38
    39

    Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin’s Lymphoma.

    Published in:
    PLoS ONE, 2016, v. 11, n. 3, p. 1, doi. 10.1371/journal.pone.0149072
    By:
    • Kluge, Regine;
    • Chavdarova, Lidia;
    • Hoffmann, Martha;
    • Kobe, Carsten;
    • Malkowski, Bogdan;
    • Montravers, Françoise;
    • Kurch, Lars;
    • Georgi, Thomas;
    • Dietlein, Markus;
    • Wallace, W. Hamish;
    • Karlen, Jonas;
    • Fernández-Teijeiro, Ana;
    • Cepelova, Michaela;
    • Wilson, Lorrain;
    • Bergstraesser, Eva;
    • Sabri, Osama;
    • Mauz-Körholz, Christine;
    • Körholz, Dieter;
    • Hasenclever, Dirk
    Publication type:
    Article
    40
    41

    Multicenter development of a PET-based risk assessment tool for product-specific outcome prediction in large B-cell lymphoma patients undergoing CAR T-cell therapy.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1361, doi. 10.1007/s00259-023-06554-0
    By:
    • Voltin, Conrad-Amadeus;
    • Paccagnella, Andrea;
    • Winkelmann, Michael;
    • Heger, Jan-Michel;
    • Casadei, Beatrice;
    • Beckmann, Laura;
    • Herrmann, Ken;
    • Dekorsy, Franziska J.;
    • Kutsch, Nadine;
    • Borchmann, Peter;
    • Fanti, Stefano;
    • Kunz, Wolfgang G.;
    • Subklewe, Marion;
    • Kobe, Carsten;
    • Zinzani, Pier Luigi;
    • Stelljes, Matthias;
    • Roth, Katrin S.;
    • Drzezga, Alexander;
    • Noppeney, Richard;
    • Rahbar, Kambiz
    Publication type:
    Article
    42

    Patterns of PET-positive residual tissue at interim restaging and risk of treatment failure in advanced-stage Hodgkin's lymphoma: an analysis of the randomized phase III HD18 trial by the German Hodgkin Study Group.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 2, p. 490, doi. 10.1007/s00259-023-06431-w
    By:
    • Ferdinandus, Justin;
    • van Heek, Lutz;
    • Roth, Katrin;
    • Dietlein, Markus;
    • Eich, Hans-Theodor;
    • Baues, Christian;
    • Borchmann, Peter;
    • Kobe, Carsten
    Publication type:
    Article
    43

    How to attract young talent to nuclear medicine step 1: a survey conducted by the EANM Oncology and Theranostics Committee to understand the expectations of the next generation.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 51, n. 1, p. 3, doi. 10.1007/s00259-023-06389-9
    By:
    • Ambrosini, Valentina;
    • Carrilho Vaz, Sofia;
    • Ahmadi Bidakhvidi, Niloefar;
    • Chanchou, Marion;
    • Cysouw, Matthijs C. F.;
    • Serani, Francesca;
    • Voltin, Conrad-Amadeus;
    • Kraeber-Bodere, Francoise;
    • Deroose, Christophe M.;
    • De Geus-Oei, Lioe-Fee;
    • Eiber, Matthias;
    • Gnanasegaran, Gopinath;
    • Gotthardt, Martin;
    • Kobe, Carsten;
    • Konijnenberg, Mark W.;
    • Nanni, Cristina;
    • Oprea Lager, Daniela E.;
    • Rahbar, Kambiz;
    • Taieb, David;
    • Mottaghy, Felix M.
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50

    Predictive value of early and late residual F-fluorodeoxyglucose and F-fluorothymidine uptake using different SUV measurements in patients with non-small-cell lung cancer treated with erlotinib.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2012, v. 39, n. 7, p. 1117, doi. 10.1007/s00259-012-2118-8
    By:
    • Kobe, Carsten;
    • Scheffler, Matthias;
    • Holstein, Arne;
    • Zander, Thomas;
    • Nogova, Lucia;
    • Lammertsma, Adriaan;
    • Boellaard, Ronald;
    • Neumaier, Bernd;
    • Ullrich, Roland;
    • Dietlein, Markus;
    • Wolf, Jürgen;
    • Kahraman, Deniz
    Publication type:
    Article